News & Events about Biovie Inc.
ORLANDO, FL / ACCESSWIRE / March 24, 2023 / RedChip Companies will air new interviews with BioVie Inc. (NASDAQ:BIVI) and iRemedy on The RedChip Money Report® on Bloomberg TV, this Saturday, March 25, at 7 p.m. Eastern Time (ET). Bloomberg TV is available in an estimated 73 million homes...
Globe Newswire
2 months ago
CARSON CITY, Nev., March 21, 2023 (GLOBE NEWSWIRE) -- BioVie Inc., (NASDAQ: BIVI) (BioVie or the Company) a clinical-stage company developing innovative drug therapies for the treatment of neurological and neurodegenerative disordersand advanced liver disease,today announceddata from its Phase 2 ...
Globe Newswire
2 months ago
Patients treated with BIV201 experienced reduced ascites fluid buildup (pCARSON CITY, Nev., March 13, 2023 (GLOBE NEWSWIRE) -- BioVie Inc., (NASDAQ: BIVI) (BioVie or the Company) a clinical-stage company developing innovative drug therapies for the treatment of neurological and neurodegenerative ...
Globe Newswire
3 months ago
CARSON CITY, Nev., March 09, 2023 (GLOBE NEWSWIRE) -- BioVie Inc. (NASDAQ: BIVI) (BioVie or the Company), a clinical-stage company developing innovative drug therapies for the treatment of neurological and neurodegenerative disordersand advanced liver disease,today announced the participation of its...
Globe Newswire
3 months ago
6 out of 20 patients treated with NE3107 experienced a morning on state while 0 out of 19 placebo-treated patients had an on (p=0.02)
Day 28 Improvement in Motor Controls vs. Day 0
Day 28 Improvement in Motor Controls vs. Day 0
CARSON CITY, Nev., March 06, 2023 (GLOBE NEWSWIRE) -- BioVie Inc., (...